9-99221864-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033087.4(ALG2):āc.31T>Cā(p.Ser11Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0723 in 1,591,414 control chromosomes in the GnomAD database, including 4,653 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_033087.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG2 | NM_033087.4 | c.31T>C | p.Ser11Pro | missense_variant | 1/2 | ENST00000476832.2 | NP_149078.1 | |
ALG2 | NR_024532.2 | n.79T>C | non_coding_transcript_exon_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG2 | ENST00000476832.2 | c.31T>C | p.Ser11Pro | missense_variant | 1/2 | 1 | NM_033087.4 | ENSP00000417764 | P1 | |
ALG2 | ENST00000238477.5 | c.31T>C | p.Ser11Pro | missense_variant, NMD_transcript_variant | 1/3 | 2 | ENSP00000432675 |
Frequencies
GnomAD3 genomes AF: 0.0549 AC: 8348AN: 152164Hom.: 312 Cov.: 32
GnomAD3 exomes AF: 0.0612 AC: 13394AN: 218840Hom.: 494 AF XY: 0.0631 AC XY: 7666AN XY: 121530
GnomAD4 exome AF: 0.0742 AC: 106746AN: 1439132Hom.: 4341 Cov.: 32 AF XY: 0.0740 AC XY: 52911AN XY: 715350
GnomAD4 genome AF: 0.0548 AC: 8345AN: 152282Hom.: 312 Cov.: 32 AF XY: 0.0536 AC XY: 3990AN XY: 74464
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 04, 2012 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 21, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at